Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT Study
- PMID: 30219767
- PMCID: PMC7497902
- DOI: 10.3899/jrheum.180353
Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT Study
Abstract
Objective: Patient-reported outcome measures (PROM) that incorporate the patient perspective have not been well established in idiopathic inflammatory myopathies (IIM). As part of our goal to develop IIM-specific PROM, the Outcome Measures in Rheumatology (OMERACT) Myositis special interest group sought to determine which aspects of disease and its effects are important to patients and healthcare providers (HCP).
Methods: Based on a prior qualitative content analysis of focus groups, an initial list of 24 candidate domains was constructed. We subsequently conducted an international survey to identify the importance of each of the 24 domains to be assessed in clinical research. Patients with IIM, their caregivers, and HCP treating IIM completed the survey.
Results: In this survey, a total of 638 respondents completed the survey, consisting of 510 patients, 101 HCP, and 27 caregivers from 48 countries. Overall, patients were more likely to rank "fatigue," "cognitive impact," and "difficulty sleeping" higher compared with HCP, who ranked "joint symptoms," "lung symptoms," and "dysphagia" higher. Both patients and providers rated muscle symptoms as their top domain. In general, patients from different countries were in agreement on which domains were most important. One notable exception was that patients from Sweden and the Netherlands ranked lung symptoms significantly higher compared to other countries including the United States and Australia (mean weighted rankings of 2.86 and 2.04 vs 0.76 and 0.80, respectively; p < 0.0001).
Conclusion: Substantial differences exist in how IIM is perceived by patients compared to HCP, with different domains prioritized. In contrast, patients' ratings across the world were largely similar.
Keywords: DELPHI; MYOSITIS; OMERACT; OUTCOME ASSESSMENT; PATIENT-REPORTED OUTCOMES.
Comment in
-
The Importance of Patient Input into Development of Outcomes in Idiopathic Inflammatory Myopathy.J Rheumatol. 2019 Jan;46(1):5-6. doi: 10.3899/jrheum.181045. J Rheumatol. 2019. PMID: 30600235 No abstract available.
References
-
- Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis.Lancet 2003;362:971–82. - PubMed
-
- Ponyi A, Borgulya G, Constantin T, Vancsa A, Gergely L, Dankó K.Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatology 2005;44:83–8. - PubMed
-
- Regardt M, Welin Henriksson E, Alexanderson H, Lundberg IE.Patients with polymyositis or dermatomyositis have reduced grip force and health-related quality of life in comparison with reference values: an observational study. Rheumatology 2011;50:578–85. - PubMed
-
- Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B, et al. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol 2001;28:2230–7. - PubMed
-
- OMERACT. [Internet. Accessed August 9, 2018] Available from: www.omeract.org.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous